PELLI N

Last name: PELLI N

2004 (v1)

Publication

Metadata-only

Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin.

TORRE, FRANCESCO PICCIOTTO, ANTONINO ROSSOL S

We have previously studied the effect of three different treatment regimens with interferon (IFN)-alpha alone or in combination with amantadine or ribavirin on viral kinetics in the first month of therapy. To understand the regulation of cytokine immune response during early inhibition of HCV replication, we analysed the longitudinal profile of...

Uploaded on: April 14, 2023
2007 (v1)

Publication

Metadata-only

Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C.

PELLI N FLOREANI A DELFINO A

No description

Uploaded on: April 14, 2023
2008 (v1)

Publication

Metadata-only

Peripheral blood serum markers for apoptosis and liver fibrosis: Are they trustworthy indicators of liver realness?

TORRE, FRANCESCO BELLIS L DELFINO A

No description

Uploaded on: April 14, 2023
2007 (v1)

Publication

Metadata-only

Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients.

BASSO M GRASSO A PERCARIO G

BACKGROUND: The re-treatment of patients who relapse after a course of standard interferon and ribavirin with pegylated interferon alfa-2b plus ribavirin is an open issue. AIMS: To evaluate efficacy and safety of treatment with pegylated interferon alfa-2b plus ribavirin and the role of early HCV-RNA assessment as a predictor of sustained...

Uploaded on: April 14, 2023

PELLI N

Recent uploads